Skip to main content

Table 5 Pharmacokinetic properties of NPFF and MiF-1 and conjugates

From: Exploring the binding interactions of NOP receptor with designed natural phytochemical-neuropeptide conjugates: an in silico and SPR study

Peptide/Conjugate

logP

Human intestinal absorption

BBB penetration

PgP inhibitor

PgP substrate

Pfizer rule

MDCK permeability

hERG blockers

NPFF

0.884

0.994

0.003

0.912

0.503

Accepted

9.25E-05

0.03

Betanin-NPFF

− 0.054

1

0.005

0

0.695

Accepted

4.47E-05

0.006

Betanin-di-NPFF

1.056

1

0

0

0.294

Accepted

1.66E-05

0

Betanin-tri-NPFF

2.574

1

0

0

0.149

Accepted

1.53E-05

0

Gallate-NPFF

0.806

1

0.001

0.192

0.852

Accepted

4.52E-05

0.016

Pomolate-NPFF

4.199

0.932

0.003

1

0.014

Accepted

1.34E-04

0.018

Sinapate-NPFF

1.643

0.996

0.002

0.999

0.984

Accepted

1.02E-04

0.024

MiF-1

− 0.367

0.01

0.137

0.009

0.83

Accepted

1.91E-05

0.032

Betanin-MiF-1

− 1.373

0.997

0.102

0

0.936

Accepted

1.14E-04

0.008

Betanin-di-MiF-1

− 1.148

0.996

0.089

0

0.881

Accepted

6.60E-05

0.008

Betanin-tri-MiF-1

− 0.193

0.999

0.056

0

0.881

Accepted

4.94E-05

0.008

Gallate-MiF-1

− 0.482

0.32

0.351

0.001

0.981

Accepted

3.30E-06

0.007

Pomolate-MiF-1

4.655

0.042

0.689

0.745

0

Accepted

2.97E-05

0.015

Sinapate-MiF-1

0.944

0.236

0.978

0.146

0.988

Accepted

5.65E-06

0.034